MEDICO INTERCONTINENTAL LIMITE

2026-08-21 BSE Web 20%LTASM-I Result 14 Aug

Price

29.17

+5.57%
O:27.76
H:31
L:26.8
C:29.17

52W Range

20.6143
+42%/-32%

Market Cap

₹29.17 Cr

Traded: ₹0.00 Cr (0.01%) 0.0x

Free Float: ₹11.30 Cr (0.04% of FF traded)

Volume · 60D trend

1.46 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:+17% 3M:+16% 6M:+1% 12M:-8%

Valuation

P/E--
P/B0.6
P/S0.3
EV/EBIT33.5

Business Strength

ROE10.8%
ROCE13.8%
OPM3.6%
NPM-13.1%

Growth (3Y CAGR)

EPS-163.2%
Sales+3.0%
Profit--
3Y Return-27.0%

Balance Sheet

Debt/Equity1.4
Debt67.1 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP-154.6%
FCF12.4 Cr
FCF 3Y Avg7.68 Cr
Cash/MCap15.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle124 days
Tradeable Free Float38.7%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
+7.0%
+4.0%
--
--
Decelerating
Sales
--
+4.0%
+3.0%
--
-14.0%
Decelerating
Profit
--
--
--
--
-221.0%
--
Return
--
-10.0%
-27.0%
-17.0%
--
Stable

Quarterly Results

Jun 2026

14 Aug
Rev
21 Cr
-3% YoY--
OPM-3.3%
NPM--
PAT
-113% YoY-4 Cr
EPS
---1.4

Mar 2026

22 May
Rev
22 Cr
+6% YoY+13% QoQ
OPM7.2%
NPM-10.4%
PAT
-156% YoY-2 Cr
EPS
-156% YoY-0.7

Dec 2025

14 Feb
Rev
20 Cr
+8% YoY-3% QoQ
OPM8.0%
NPM-8.4%
PAT
-119% YoY-2 Cr
EPS
-119% YoY-0.2

Sep 2025

PDF
Rev
20 Cr
-44% YoY-4% QoQ
OPM-4.3%
NPM-22.1%
PAT
-201% YoY-5 Cr
EPS
-201% YoY-1.6

Jun 2025

PDF
Rev
21 Cr
+11% YoY+1% QoQ
OPM3.2%
NPM-11.7%
PAT
-163% YoY-2 Cr
EPS
-163% YoY-0.7

Mar 2025

PDF
Rev
21 Cr
+35% YoY+15% QoQ
OPM9.2%
NPM5.5%
PAT
+12% YoY1 Cr
EPS
+13% YoY1.2

Dec 2024

PDF
Rev
18 Cr
+29% YoY-49% QoQ
OPM10.4%
NPM6.3%
PAT
+15% YoY1 Cr
EPS
+15% YoY1.2

Sep 2024

PDF
Rev
36 Cr
+113% YoY+89% QoQ
OPM7.4%
NPM4.5%
PAT
+87% YoY2 Cr
EPS
+87% YoY1.6

Jun 2024

PDF
Rev
19 Cr
-21% YoY+23% QoQ
OPM8.5%
NPM5.6%
PAT
+6% YoY1 Cr
EPS
+6% YoY1.1

Mar 2024

PDF
Rev
16 Cr
-46% YoY+10% QoQ
OPM9.9%
NPM6.6%
PAT
+3% YoY1 Cr
EPS
+3% YoY1.0

Dec 2023

PDF
Rev
14 Cr
-21% YoY-17% QoQ
OPM10.5%
NPM7.2%
PAT
+17% YoY1 Cr
EPS
+17% YoY1.0

Sep 2023

PDF
Rev
17 Cr
+5% YoY-29% QoQ
OPM7.7%
NPM5.1%
PAT
+1% YoY1 Cr
EPS
--0.9

Jun 2023

PDF
Rev
24 Cr
+88% YoY-16% QoQ
OPM6.1%
NPM4.2%
PAT
+19% YoY1 Cr
EPS
--1.0

Mar 2023

Rev
29 Cr
--+61% QoQ
OPM4.7%
NPM3.5%
PAT
+16% YoY1 Cr
EPS
--1.0

Dec 2022

Rev
18 Cr
----
OPM6.1%
NPM4.8%
PAT
+16% YoY1 Cr
EPS
--0.9

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity1.43
Interest Coverage3.2x
Promoter Pledge0.0%
Borrowings67 Cr

Efficiency

Receivable Days119 days
Inventory Days87 days
Payable Days82 days
Cash Conversion cycle124 days

Cash Position

Operating Cash Flow17 Cr
Investing Cash Flow2 Cr
Financing Cash Flow-16 Cr
Free Cash Flow12 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Mar 2023
Dec 2022
Sales212220202121183619161417242918
Expenses212118212119173418141316232817
Operating Profit-122-112232211111
OPM %-3.3%7.2%8.0%-4.3%3.2%9.2%10.4%7.4%8.5%9.9%10.5%7.7%6.1%4.7%6.1%
Other Income000100000000000
Interest222220000000000
Depreciation111210000000000
Profit Before Tax-4-2-1-4-21221111111
Tax %10.3%51.3%20.0%4.6%23.9%22.4%27.4%29.6%27.5%28.3%26.1%29.3%26.1%30.3%25.9%
Net Profit-4-2-2-5-21121111111
Exceptional Items------------------------------
EPS (Rs)-1.4-0.7-0.2-1.6-0.71.21.21.61.11.01.00.91.01.00.9
Sales Growth (YoY)-3.0%6.3%7.7%-44.0%10.7%34.8%29.3%112.9%-20.6%-45.9%-21.1%5.3%88.4%----
Sales Growth (QoQ)--13.3%-2.7%-4.5%0.9%14.8%-49.4%89.1%22.8%10.2%-16.8%-29.5%-16.3%60.5%--
OP Growth (YoY)-201.5%-17.0%-16.8%-132.5%-58.5%25.2%28.2%106.9%10.8%14.8%34.2%--------
OP Growth (QoQ)-142.9%1.3%280.7%-229.4%-64.9%1.6%-29.5%65.2%5.8%4.0%13.7%-11.5%9.6%21.6%--
Profit Growth (YoY)-113.0%-156.0%-119.0%-201.0%-163.0%12.0%15.0%87.0%6.0%3.0%17.0%1.0%19.0%16.0%16.0%
EPS Growth (YoY)---155.6%-118.8%-201.2%-163.0%12.5%14.7%87.4%5.9%3.0%17.2%--------
EPS Growth (QoQ)---195.4%86.7%-142.7%-158.1%0.0%-28.2%50.9%3.9%2.0%17.2%-14.7%1.0%16.1%--
OP Margin--7.2%8.0%-4.3%3.2%9.2%10.4%7.4%8.5%9.9%10.5%7.7%6.1%4.7%6.1%
Net Margin---10.4%-8.4%-22.1%-11.7%5.5%6.3%4.5%5.6%6.6%7.2%5.1%4.2%3.5%4.8%
Material Cost %81.0%69.0%72.0%82.0%75.0%79.0%76.0%78.0%79.0%70.0%75.0%77.0%82.0%82.0%85.0%
Employee Cost %12.0%10.0%12.0%11.0%9.0%7.0%7.0%3.0%5.0%8.0%7.0%5.0%3.0%4.0%4.0%
P/S0.350.340.28------------------------
P/E------------------------------
P/B0.620.600.48------------------------

Shareholding Pattern

Shareholders:3.5K (+221.6%)
Current MixJun 2026

Exchange Filings

50
Company Update17 Aug 2026

Announcement under Regulation 30 (LODR) - Newspaper Publication

Result14 Aug 2026

Results for the Quarter ended 30 June 2026

Board Meeting14 Aug 2026

Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company ....

Board Meeting05 Aug 2026

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve and take on record ....

Company Update09 Jul 2026

Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Insider Trading / SAST29 Jun 2026

Closure of Trading Windo

Insider Trading / SAST25 Jun 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Shah & PACs

Company Update25 Jun 2026

Submission of Disclosure

Company Update23 May 2026

Newspaper Publication

Company Update22 May 2026

Intimation of Re-appointment of an Internal Auditors.

Result22 May 2026

Results for the quarter and financial year ended March 31, 2026

Board Meeting22 May 2026

Outcome of Board meeting dated May 22, 2026.

Board Meeting14 May 2026

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve and take on record ....

Company Update16 Apr 2026

Annual Secretarial Compliance Report under Regulation 24A of the SEBI (LODR) Regulations, 2015 for the financial year ended 31st March, 2026.

Others08 Apr 2026

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Company Update04 Apr 2026

Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Insider Trading / SAST30 Mar 2026

Closure of Trading Window

Company Update16 Feb 2026

Newspaper Publication

Result14 Feb 2026

Results for the quarter and nine months ended December 31, 2025.

Board Meeting14 Feb 2026

Results for the quarter and nine months ended December 31, 2025

Board Meeting04 Feb 2026

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve and take on record ....

Company Update08 Jan 2026

Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Insider Trading / SAST29 Dec 2025

Closure of Trading Window

Insider Trading / SAST26 Dec 2025

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Samir Dilipkumar Shah & PACs

Company Update26 Dec 2025

Submission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Company Update15 Nov 2025

Announcement under Regulation 30 (LODR) - Newspaper Publication

Result14 Nov 2025

Results - Financial results for the quarter and half year ended September 30, 2025

Board Meeting14 Nov 2025

Outcome of Board meeting held on November 14, 2025

Board Meeting06 Nov 2025

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Board Meeting Intimation ....

Company Update09 Oct 2025

Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Company Update01 Oct 2025

Announcement under Regulation 30 (LODR) - Annual General Meeting updates

AGM/EGM01 Oct 2025

VOTING RESULTS ALONG WITH SCRUTINIZER REPORT

AGM/EGM30 Sept 2025

Proceedings of the 41st Annual General Meeting of the Company held on September 30, 2025.

Insider Trading / SAST29 Sept 2025

Closure of Trading Window

Company Update08 Sept 2025

Newspaper Publication

Others06 Sept 2025

Annual Report for the FY 2024-25

Corp. Action30 Aug 2025

Intimation the Book Closure & Annual General Meeting.

Company Update18 Aug 2025

Newspaper Publication

Board Meeting06 Aug 2025

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve With reference to the ....

Company Update14 Jul 2025

Appointment of Company Secretary & Compliance Officer of the Company w.e.f. 14th July, 2025.

Others14 Jul 2025

Appointment of Company Secretary & Compliance Officer of the Company w.e.f. 14th July, 2025.

Company Update07 Jul 2025

Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Insider Trading / SAST28 Jun 2025

Closure of Trading Window

Company Update31 May 2025

Newspaper publication

Company Update24 May 2025

Annual Secretarial Compliance Report for the period ended 31.03.2025

Board Meeting17 May 2025

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve and take on record ....

Others22 Apr 2025

With reference to the subject captioned above, in compliance of the Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, ....

Company Update22 Apr 2025

Resignation of Company Secretary and Compliance Officer w.e.f. closing hours of 22nd April, 2025.

Others08 Apr 2025

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

Company Update07 Apr 2025

Announcement under Regulation 30 (LODR) - Meeting updates

Annual Reports

10

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016